TY - JOUR T1 - Estimation of the Time-Varying Reproduction Number of 2019-nCoV Outbreak in China JF - medRxiv DO - 10.1101/2020.02.08.20021253 SP - 2020.02.08.20021253 AU - Chong You AU - Yuhao Deng AU - Wenjie Hu AU - Jiarui Sun AU - Qiushi Lin AU - Feng Zhou AU - Cheng Heng Pang AU - Yuan Zhang AU - Zhengchao Chen AU - Xiao-Hua Zhou Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/02/11/2020.02.08.20021253.abstract N2 - Background The 2019-nCoV outbreak in Wuhan, China has attracted world-wide attention. As of February 5, 2020, a total of 24433 cases of novel coronavirus-infected pneumonia associated with 2019-nCov were confirmed by the National Health Commission of China.Methods Three approaches, namely Poisson likelihood-based method (ML), exponential growth rate-based method (EGR) and stochastic Susceptible-Infected-Removed dynamic model-based method (SIR), were implemented to estimate the basic and controlled reproduction numbers.Results A total of 71 chains of transmission together with dates of symptoms onset and 67 dates of infections were identified among 5405 confirmed cases outside Hubei as reported by February 2, 2020. Based on this information, we find the serial interval having an average of 4.41 days with a standard deviation of 3.17 days and the infectious period having an average of 10.91 days with a standard deviation of 3.95 days. Although the estimated controlled reproduction numbers Rc produced by all three methods in all different regions are significantly smaller compared with the basic reproduction numbers R0, they are still greater than one.Conclusions Although the controlled reproduction number is declining, it is still larger than one. Additional efforts are needed to further reduce the Rc to below one in order to end the current epidemic.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo funding.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data are collected from the website of China CDC. http://2019ncov.chinacdc.cn/2019-nCoV/ ER -